Diagnostic Approach to Mucus‑Containing Diarrhea in Assisted‑Living Residents

Initial Priority Testing

• Test for Clostridioides difficile immediately in any resident with mucus‑containing diarrhea, because healthcare‑associated transmission and prior antibiotic exposure are common in assisted‑living settings. 1, 2
• Order a comprehensive bacterial stool culture panel (Salmonella, Shigella, Campylobacter, Yersinia, and Shiga‑toxin‑producing E. coli – O157 by culture and non‑O157 by toxin assay) as the next step after C. difficile testing. 3, 1, 4
• Even in the absence of fever or gross blood, mucoid stools alone justify an infectious work‑up because they are a marker of possible enteric infection. 1, 5

Outbreak Considerations

• Coordinate with the facility’s infection‑control team to identify whether other residents are experiencing similar symptoms; this guides the need for expanded testing. 5, 3
• When multiple cases occur in a congregate‑living setting, broaden pathogen testing to include bacterial, viral, and parasitic agents regardless of individual symptom severity. 5, 6
• Notify public‑health authorities promptly if an outbreak is suspected. 2

Persistent Symptoms (≥ 7–14 days)

• Collect three fresh stool specimens for ova, cysts, and parasites (overall sensitivity 60–90%). 7
• If the initial ova‑and‑parasite work‑up is negative, perform a Giardia ELISA (≈ 92 % sensitivity, 98 % specificity). 7
• In immunocompromised residents, add testing for Cryptosporidium, Cyclospora, and other protozoa. 1, 4

Immunodeficiency‑Related Evaluation

• Include HIV testing when the resident’s immune status is unknown or at risk. 7
• Expand the parasitic panel to cover Cryptosporidium, Cyclospora, Cystoisospora, and microsporidia in immunodeficient patients. 1, 6
• Add viral stool studies and a comprehensive bacterial culture when immunodeficiency is present. 4

Chronic Diarrhea Evaluation (≥ 4 weeks)

• If infectious studies are negative, obtain celiac disease serologies (tissue transglutaminase IgA with total IgA) as a mandatory step in chronic diarrhea assessment. 7

Interpretation Pitfalls

• Multiplex molecular panels detect nucleic acid from both viable and non‑viable organisms; positive results may reflect colonisation rather than active infection. 1, 2, 6
• Routine blood cultures are not indicated for isolated mucus‑containing diarrhea unless the resident develops fever, sepsis, or other systemic signs. 1, 4

Evidence‑Based Recommendations for Evaluating Persistent Watery Diarrhea After a Negative C. difficile Test

Diagnostic Testing

• Repeat C. difficile testing with a two‑step algorithm (glutamate dehydrogenase or PCR screen followed by toxin EIA) when clinical suspicion remains high; a single negative test has a negative predictive value of 97 % (≈ 3 % of true infections may be missed). 8
• Obtain three separate fresh stool specimens for ova, cysts, and parasites to achieve 60–90 % sensitivity for protozoan detection in patients with diarrhea lasting ≥ 7–14 days. 8
• If the initial ova‑and‑parasite exam is negative, order a Giardia ELISA (≈ 92 % sensitivity, 98 % specificity), which largely replaces the need for intestinal biopsies. 8

Serologic and Inflammatory Markers

• Include celiac disease serology (tissue transglutaminase IgA with total IgA) as a mandatory component of the work‑up for chronic diarrhea (≥ 4 weeks) when infectious studies are negative. 8
• Measure fecal calprotectin to distinguish inflammatory from non‑inflammatory etiologies and to guide the decision for endoscopic evaluation. 8
• Perform a baseline screening panel that includes a complete blood count, ferritin, and thyroid‑function tests. 8

Interpretation of Molecular Results

• Multiplex PCR panels detect nucleic acid from both viable and non‑viable organisms; therefore a positive result may represent colonisation rather than active infection, particularly for C. difficile. 8
• Avoid initiating antimicrobial therapy solely on the basis of a positive PCR without evidence of toxin production, as unnecessary treatment can contribute to post‑infectious irritable bowel syndrome after C. difficile infection. 8

Additional Clinical Considerations

• Offer HIV testing when the patient’s immune status is unknown or risk factors are present, because a positive result substantially alters the differential diagnosis for persistent diarrhea. 8